Katja Seipel

Publication Activity (10 Years)

Years Active: 2020-2024
Publications (10 Years): 28

Top Topics

Acute Myeloid Leukemia

Multiple Myeloma

Epstein Barr Virus

Top Venues

Current issues in molecular biology

Current oncology (Toronto, Ont.)

International journal of molecular sciences

This page only lists publications with an associated author ORCID identifier.

Publications

Katja Seipel, Harpreet Mandhair, Vera Ulrike Bacher, Thomas Pabst
FLT3 and IRAK4 Inhibitor Emavusertib in Combination with BH3-Mimetics in the Treatment of Acute Myeloid Leukemia. Current issues in molecular biology 46 (4) (2024)
Katja Seipel, Harpreet Mandhair, Vera Ulrike Bacher, Thomas Pabst
FLT3 and IRAK4 Inhibitor Emavusertib in Combination with BH3-Mimetics in the Treatment of Acute Myeloid Leukemia. Current issues in molecular biology 46 (4) (2024)
Katja Seipel, Nuria Z Veglio, Henning Nilius, Barbara Jeker, Vera Ulrike Bacher, Thomas Pabst
Rising Prevalence of Low-Frequency PPM1D Gene Mutations after Second HDCT in Multiple Myeloma. Current issues in molecular biology 46 (8) (2024)
Katja Seipel, Nuria Z Veglio, Henning Nilius, Barbara Jeker, Vera Ulrike Bacher, Thomas Pabst
Rising Prevalence of Low-Frequency PPM1D Gene Mutations after Second HDCT in Multiple Myeloma. Current issues in molecular biology 46 (8) (2024)
Danaë Martinez Flores, Dilara Akhoundova, Katja Seipel, Myriam Legros, Marie-Noelle Kronig, Michael Daskalakis, Vera Ulrike Bacher, Thomas Pabst
Gemtuzumab Ozogamicin and Stem Cell Mobilization for Autologous Stem Cell Transplantation in Favorable Risk Acute Myeloid Leukemia. Biomedicines 12 (7) (2024)
Katja Seipel, Nuria Z Veglio, Henning Nilius, Barbara Jeker, Vera Ulrike Bacher, Thomas Pabst
Rising Prevalence of Low-Frequency PPM1D Gene Mutations after Second HDCT in Multiple Myeloma. Current issues in molecular biology 46 (8) (2024)
Danaë Martinez Flores, Dilara Akhoundova, Katja Seipel, Myriam Legros, Marie-Noelle Kronig, Michael Daskalakis, Vera Ulrike Bacher, Thomas Pabst
Gemtuzumab Ozogamicin and Stem Cell Mobilization for Autologous Stem Cell Transplantation in Favorable Risk Acute Myeloid Leukemia. Biomedicines 12 (7) (2024)
Danaë Martinez Flores, Dilara Akhoundova, Katja Seipel, Myriam Legros, Marie-Noelle Kronig, Michael Daskalakis, Vera Ulrike Bacher, Thomas Pabst
Gemtuzumab Ozogamicin and Stem Cell Mobilization for Autologous Stem Cell Transplantation in Favorable Risk Acute Myeloid Leukemia. Biomedicines 12 (7) (2024)
Katja Seipel, Harpreet Mandhair, Vera Ulrike Bacher, Thomas Pabst
FLT3 and IRAK4 Inhibitor Emavusertib in Combination with BH3-Mimetics in the Treatment of Acute Myeloid Leukemia. Current issues in molecular biology 46 (4) (2024)
Valerie Wittibschlager, Vera Ulrike Bacher, Katja Seipel, Naomi A Porret, Gertrud Wiedemann, Claudia Haslebacher, Michèle Hoffmann, Michael Daskalakis, Dilara Akhoundova, Thomas Pabst
CAR T-Cell Persistence Correlates with Improved Outcome in Patients with B-Cell Lymphoma. International journal of molecular sciences 24 (6) (2023)
Katja Seipel, Michèle Frey, Henning Nilius, Dilara Akhoundova, Yara Banz, Vera Ulrike Bacher, Thomas Pabst
Low-Frequency PPM1D Gene Mutations Affect Treatment Response to CD19-Targeted CAR T-Cell Therapy in Large B-Cell Lymphoma. Current oncology (Toronto, Ont.) 30 (12) (2023)
Valerie Wittibschlager, Vera Ulrike Bacher, Katja Seipel, Naomi A Porret, Gertrud Wiedemann, Claudia Haslebacher, Michèle Hoffmann, Michael Daskalakis, Dilara Akhoundova, Thomas Pabst
CAR T-Cell Persistence Correlates with Improved Outcome in Patients with B-Cell Lymphoma. International journal of molecular sciences 24 (6) (2023)
Katja Seipel, Mariesol Abbühl, Vera Ulrike Bacher, Henning Nilius, Michael Daskalakis, Thomas Pabst
Clinical Impact of Single Nucleotide Polymorphism in CD-19 on Treatment Outcome in FMC63-CAR-T Cell Therapy. Cancers 15 (11) (2023)
Katja Seipel, Michèle Frey, Henning Nilius, Dilara Akhoundova, Yara Banz, Vera Ulrike Bacher, Thomas Pabst
Low-Frequency PPM1D Gene Mutations Affect Treatment Response to CD19-Targeted CAR T-Cell Therapy in Large B-Cell Lymphoma. Current oncology (Toronto, Ont.) 30 (12) (2023)
Valerie Wittibschlager, Vera Ulrike Bacher, Katja Seipel, Naomi A Porret, Gertrud Wiedemann, Claudia Haslebacher, Michèle Hoffmann, Michael Daskalakis, Dilara Akhoundova, Thomas Pabst
CAR T-Cell Persistence Correlates with Improved Outcome in Patients with B-Cell Lymphoma. International journal of molecular sciences 24 (6) (2023)
Katja Seipel, Michèle Frey, Henning Nilius, Dilara Akhoundova, Yara Banz, Vera Ulrike Bacher, Thomas Pabst
Low-Frequency PPM1D Gene Mutations Affect Treatment Response to CD19-Targeted CAR T-Cell Therapy in Large B-Cell Lymphoma. Current oncology (Toronto, Ont.) 30 (12) (2023)
Katja Seipel, Michèle Frey, Henning Nilius, Dilara Akhoundova, Yara Banz, Vera Ulrike Bacher, Thomas Pabst
Low-Frequency PPM1D Gene Mutations Affect Treatment Response to CD19-Targeted CAR T-Cell Therapy in Large B-Cell Lymphoma. Current oncology (Toronto, Ont.) 30 (12) (2023)
Selina Bühler, Dilara Akhoundova, Barbara Jeker, Myriam Legros, Katja Seipel, Michael Daskalakis, Vera Ulrike Bacher, Thomas Pabst
Stem Cell Mobilization with Ixazomib and G-CSF in Patients with Multiple Myeloma. Cancers 15 (2) (2023)
Katja Seipel, Michèle Frey, Henning Nilius, Dilara Akhoundova, Yara Banz, Vera Ulrike Bacher, Thomas Pabst
Low-Frequency PPM1D Gene Mutations Affect Treatment Response to CD19-Targeted CAR T-Cell Therapy in Large B-Cell Lymphoma. Current oncology (Toronto, Ont.) 30 (12) (2023)
Katja Seipel, Scarlett Kohler, Vera Ulrike Bacher, Thomas Pabst
HSP90 Inhibitor PU-H71 in Combination with BH3-Mimetics in the Treatment of Acute Myeloid Leukemia. Current issues in molecular biology 45 (9) (2023)
Cédric Gillich, Dilara Akhoundova, Michael Hayoz, Yolanda Aebi, Carlo R Largiadèr, Katja Seipel, Michael Daskalakis, Vera Ulrike Bacher, Thomas Pabst
Efficacy and Safety of High-Dose Chemotherapy with Treosulfan and Melphalan in Multiple Myeloma. Cancers 15 (10) (2023)
Selina Bühler, Dilara Akhoundova, Barbara Jeker, Myriam Legros, Katja Seipel, Michael Daskalakis, Vera Ulrike Bacher, Thomas Pabst
Stem Cell Mobilization with Ixazomib and G-CSF in Patients with Multiple Myeloma. Cancers 15 (2) (2023)
Katja Seipel, Naomi A Porret, Gertrud Wiedemann, Barbara Jeker, Vera Ulrike Bacher, Thomas Pabst
sBCMA Plasma Level Dynamics and Anti-BCMA CAR-T-Cell Treatment in Relapsed Multiple Myeloma. Current issues in molecular biology 44 (4) (2022)
Katja Seipel, Yvo Brügger, Harpreet K Mandhair, Vera Ulrike Bacher, Thomas Pabst
Rationale for Combining the BCL2 Inhibitor Venetoclax with the PI3K Inhibitor Bimiralisib in the Treatment of IDH2- and FLT3-Mutated Acute Myeloid Leukemia. International journal of molecular sciences 23 (20) (2022)
Vera Rentsch, Katja Seipel, Yara Banz, Gertrud Wiedemann, Naomi A Porret, Vera Ulrike Bacher, Thomas Pabst
Glofitamab Treatment in Relapsed or Refractory DLBCL after CAR T-Cell Therapy. Cancers 14 (10) (2022)
Katja Seipel, Basil Kopp, Vera Ulrike Bacher, Thomas Pabst
BMI1-Inhibitor PTC596 in Combination with MCL1 Inhibitor S63845 or MEK Inhibitor Trametinib in the Treatment of Acute Leukemia. Cancers 13 (3) (2021)
Katja Seipel, Carolyn Graber, Laura Flückiger, Vera Ulrike Bacher, Thomas Pabst
Rationale for a Combination Therapy with the STAT5 Inhibitor AC-4-130 and the MCL1 Inhibitor S63845 in the Treatment of FLT3-Mutated or TET2-Mutated Acute Myeloid Leukemia. International journal of molecular sciences 22 (15) (2021)
Jeffrey R Idle, Katja Seipel, Vera Ulrike Bacher, Thomas Pabst, Diren Beyoğlu
(2R,3S)-Dihydroxybutanoic Acid Synthesis as a Novel Metabolic Function of Mutant Isocitrate Dehydrogenase 1 and 2 in Acute Myeloid Leukemia. Cancers 12 (10) (2020)